Arizona State Retirement System lifted its position in Piper Sandler Companies (NYSE:PIPR – Free Report) by 0.8% in the ...

Charles Schwab Investment Management Inc. lowered its position in shares of Piper Sandler Companies (NYSE:PIPR – Free Report) by 0.1% in the fourth quarter, according to its most recent Form 13F ...

Atlas Energy Solutions launched at Piper Sandler with an Overweight rating, attracted to multiple growth avenues, ...

Myriad Genetics (NASDAQ:MYGN) traded higher on Wednesday after Piper Sandler upgraded the cancer test developer to Overweight ...

We recently compiled a list of the 8 Fastest Growing AI Stocks To Buy Right Now. In this article, we are going to take a look ...

Short sellers have been increasing their bets, with short interest now accounting for 6.1% of the stock's available float.

Piper Sandler expects the bill to pass along party lines. "Once it makes it over to the Senate, at least eight Democrats will ...

Artificial intelligence took the tech world by storm at the end of 2022, with the introduction of ChatGPT and generative AI. The past few years ...

Fintel reports that on March 11, 2025, Piper Sandler upgraded their outlook for Redfin (NasdaqGS:RDFN) from Underweight to Neutral. Analyst Price Forecast Suggests 19.26% Downside As of March 4, 2025, ...

Daner Wealth Management LLC acquired 1,081 shares of Alphabet, valued at approximately $217,000, in Q4. Institutional ...

Neivert covers the Basic Materials sector, focusing on stocks such as Methanex, Albemarle, and Celanese. According to TipRanks, Neivert has an average return of -3.6% and a 41.37% success rate on ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Axsome Therapeutics ( AXSM – Research Report) today and set a price target of $148.00. The company’s shares closed yesterday at $118.78.